Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.

This study supports that properly selected patients with recurrent, apparent TaLG NMIBC can be safely managed with office fulguration under local anesthesia with occasional TURBT for larger or numerous recurrent tumours, without compromising long-term oncological outcomes. This approach could generate substantial cost-saving to health care systems, is patient-friendly and could be adopted more widely.